Sarafem: Effective Relief for Premenstrual Dysphoric Disorder
Sarafem
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | 0.78 $ | 46.80 $ (0%) | 🛒 Add to cart |
| 90 | 0.73 $ | 70.20 $ 65.52 $ (7%) | 🛒 Add to cart |
| 180 | 0.66 $ | 140.40 $ 119.34 $ (15%) | 🛒 Add to cart |
| 270 | 0.64 $ | 210.60 $ 171.99 $ (18%) | 🛒 Add to cart |
| 360 | 0.63 $
Best per pill | 280.80 $ 225.81 $ (20%) | 🛒 Add to cart |
Similar products
Sarafem is a prescription medication specifically formulated to treat the emotional and physical symptoms associated with Premenstrual Dysphoric Disorder (PMDD). It contains the active ingredient fluoxetine hydrochloride, a selective serotonin reuptake inhibitor (SSRI) that helps restore the balance of serotonin in the brain, a neurotransmitter known to influence mood, sleep, and pain perception. By targeting the underlying neurochemical imbalances linked to PMDD, Sarafem offers a clinically validated approach to managing severe premenstrual symptoms, allowing patients to regain control over their daily lives and emotional well-being. This medication is intended for use under the supervision of a healthcare provider and requires a comprehensive evaluation to ensure it is appropriate for the individual’s condition.
Features
- Contains fluoxetine hydrochloride, an SSRI with established efficacy in mood regulation
- Available in easy-to-swallow capsules in multiple dosage strengths (10 mg, 20 mg)
- Specifically indicated for the treatment of Premenstrual Dysphoric Disorder (PMDD)
- Regulated and approved by the FDA for safety and therapeutic effectiveness
- Manufactured under strict quality control standards to ensure purity and consistency
Benefits
- Reduces severe mood swings, irritability, and tension associated with PMDD
- Alleviates physical symptoms such as bloating, breast tenderness, and headaches
- Improves overall emotional stability and daily functioning during the luteal phase
- Helps restore a balanced serotonin level, supporting better sleep and appetite
- Enhances quality of life by minimizing the disruptive impact of PMDD on work and relationships
- Provides a targeted, non-hormonal treatment option for PMDD management
Common use
Sarafem is primarily prescribed for the treatment of Premenstrual Dysphoric Disorder (PMDD), a severe form of premenstrual syndrome characterized by significant emotional and physical symptoms that interfere with daily activities and interpersonal relationships. It is used to manage symptoms such as marked irritability, anxiety, depressed mood, and somatic complaints including joint or muscle pain and fatigue. Sarafem is typically administered intermittently or continuously, as directed by a healthcare provider, based on the patient’s symptom pattern and medical history.
Dosage and direction
The recommended dosage of Sarafem for PMDD is 20 mg per day, taken orally, with or without food. Depending on individual response and tolerability, the dose may be adjusted by a healthcare provider, but should not exceed 80 mg per day. Administration may be continuous throughout the menstrual cycle or limited to the luteal phase (the 14 days prior to the onset of menses). It is important to follow the prescribing physician’s instructions precisely and not to alter the dose without consultation. Swallow the capsule whole with water; do not crush, chew, or open it.
Precautions
Before using Sarafem, patients should inform their healthcare provider of any history of bipolar disorder, seizures, liver or kidney disease, or bleeding disorders. Use with caution in elderly patients due to potential for hyponatremia or increased risk of bleeding. Sarafem may cause drowsiness or dizziness; avoid driving or operating heavy machinery until the individual’s response to the medication is known. Regular monitoring of mood and symptoms is advised, especially during the initial weeks of treatment. Patients should avoid alcohol while taking Sarafem, as it may exacerbate side effects.
Contraindications
Sarafem is contraindicated in patients with known hypersensitivity to fluoxetine or any component of the formulation. It must not be used concomitantly with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy due to the risk of serotonin syndrome. Use is also contraindicated in patients taking pimozide or thioridazine. Sarafem is not recommended for use in patients with uncontrolled narrow-angle glaucoma.
Possible side effect
Common side effects may include nausea, headache, insomnia, fatigue, drowsiness, diarrhea, dry mouth, increased sweating, and decreased appetite. Some patients may experience sexual dysfunction, such as decreased libido or delayed orgasm. Less frequently, anxiety, nervousness, rash, or weight changes may occur. Serious side effects, though rare, can include serotonin syndrome, abnormal bleeding, hyponatremia, manic episodes, seizures, or angle-closure glaucoma. Any unusual or severe symptoms should be reported to a healthcare provider immediately.
Drug interaction
Sarafem may interact with several medications, including MAOIs (risk of serotonin syndrome), other SSRIs or serotonergic drugs, NSAIDs or anticoagulants (increased bleeding risk), drugs metabolized by CYP2D6 (e.g., tricyclic antidepressants, antipsychotics), and triptans. It may also interact with tryptophan, tramadol, and certain antiarrhythmics. Always inform the prescribing physician of all current medications, including over-the-counter drugs and supplements.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Consistent daily administration (if prescribed daily) is important for maintaining stable serotonin levels and effectiveness.
Overdose
Symptoms of overdose may include nausea, vomiting, agitation, restlessness, hypomania, seizures, or serotonin syndrome. In severe cases, cardiovascular effects or coma may occur. If an overdose is suspected, seek immediate medical attention or contact a poison control center. Treatment is supportive and may include activated charcoal, gastric lavage, and monitoring of vital signs.
Storage
Store Sarafem at room temperature (20°–25°C or 68°–77°F), in a tightly closed container, away from light, moisture, and heat. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Dispose of unused medication properly according to local guidelines or through a drug take-back program.
Disclaimer
This information is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or stopping any medication. Individual results may vary, and only a physician can determine if Sarafem is appropriate based on a patient’s specific health profile.
Reviews
Clinical studies and patient reports indicate that Sarafem is effective in reducing the severity of PMDD symptoms for many individuals. Users often note improvements in mood stability, reduced irritability, and better overall functioning during the premenstrual phase. Some report side effects such as initial nausea or sleep disturbances, which often subside with continued use. Overall, Sarafem is regarded as a valuable option for those with moderate to severe PMDD when used under medical supervision.